Autistic-like behavior, spontaneous seizures, and increased neuronal excitability in a Scn8a mouse model
- PMID: 33658654
- PMCID: PMC8429750
- DOI: 10.1038/s41386-021-00985-9
Autistic-like behavior, spontaneous seizures, and increased neuronal excitability in a Scn8a mouse model
Abstract
Patients with SCN8A epileptic encephalopathy exhibit a range of clinical features, including multiple seizure types, movement disorders, and behavioral abnormalities, such as developmental delay, mild-to-severe intellectual disability, and autism. Recently, the de novo heterozygous SCN8A R1620L mutation was identified in an individual with autism, intellectual disability, and behavioral seizures without accompanying electrographic seizure activity. To date, the effects of SCN8A mutations that are primarily associated with behavioral abnormalities have not been studied in a mouse model. To better understand the phenotypic and functional consequences of the R1620L mutation, we used CRISPR/Cas9 technology to generate mice expressing the corresponding SCN8A amino acid substitution. Homozygous mutants exhibit tremors and a maximum lifespan of 22 days, while heterozygous mutants (RL/+) exhibit autistic-like behaviors, such as hyperactivity and learning and social deficits, increased seizure susceptibility, and spontaneous seizures. Current clamp analyses revealed a reduced threshold for firing action potentials in heterozygous CA3 pyramidal neurons and reduced firing frequency, suggesting that the R1620L mutation has both gain- and loss-of-function effects. In vivo calcium imaging using miniscopes in freely moving RL/+ mutants showed hyperexcitability of cortical excitatory neurons that is likely to increase seizure susceptibility. Finally, we found that oxcarbazepine and Huperzine A, a sodium channel blocker and reversible acetylcholinesterase inhibitor, respectively, were capable of conferring robust protection against induced seizures in RL/+ mutants. This mouse line will provide the opportunity to better understand the range of clinical phenotypes associated with SCN8A mutations and to develop new therapeutic approaches.
© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.
Figures





Similar articles
-
Aberrant Sodium Channel Currents and Hyperexcitability of Medial Entorhinal Cortex Neurons in a Mouse Model of SCN8A Encephalopathy.J Neurosci. 2017 Aug 9;37(32):7643-7655. doi: 10.1523/JNEUROSCI.2709-16.2017. Epub 2017 Jul 4. J Neurosci. 2017. PMID: 28676574 Free PMC article.
-
Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy.Hum Mol Genet. 2015 Jan 15;24(2):506-15. doi: 10.1093/hmg/ddu470. Epub 2014 Sep 16. Hum Mol Genet. 2015. PMID: 25227913 Free PMC article.
-
Neuronal hyperexcitability in a mouse model of SCN8A epileptic encephalopathy.Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2383-2388. doi: 10.1073/pnas.1616821114. Epub 2017 Feb 13. Proc Natl Acad Sci U S A. 2017. PMID: 28193882 Free PMC article.
-
SCN8A Epilepsy, Developmental Encephalopathy, and Related Disorders.Pediatr Neurol. 2021 Sep;122:76-83. doi: 10.1016/j.pediatrneurol.2021.06.011. Epub 2021 Aug 3. Pediatr Neurol. 2021. PMID: 34353676 Review.
-
SCN8A encephalopathy: Mechanisms and models.Epilepsia. 2019 Dec;60 Suppl 3(Suppl 3):S86-S91. doi: 10.1111/epi.14703. Epilepsia. 2019. PMID: 31904118 Free PMC article. Review.
Cited by
-
Gaining Awareness of Increasingly Persistent SCN1A Mutations.Epilepsy Curr. 2023 Mar 26;23(3):179-181. doi: 10.1177/15357597231157484. eCollection 2023 May-Jun. Epilepsy Curr. 2023. PMID: 37334423 Free PMC article. No abstract available.
-
Patient leadership and partnerships accelerate therapies for SCN8A and other developmental and epileptic encephalopathies.Ther Adv Rare Dis. 2025 Feb 20;6:26330040241252449. doi: 10.1177/26330040241252449. eCollection 2025 Jan-Dec. Ther Adv Rare Dis. 2025. PMID: 39989508 Free PMC article. Review.
-
Autonomic dysfunction in epilepsy mouse models with implications for SUDEP research.Front Neurol. 2023 Jan 6;13:1040648. doi: 10.3389/fneur.2022.1040648. eCollection 2022. Front Neurol. 2023. PMID: 36686527 Free PMC article. Review.
-
Somatostatin-expressing interneurons of prefrontal cortex modulate social deficits in the Magel2 mouse model of autism.Mol Autism. 2025 Mar 11;16(1):18. doi: 10.1186/s13229-025-00653-5. Mol Autism. 2025. PMID: 40069835 Free PMC article.
-
Epilepsy insights revealed by intravital functional optical imaging.Front Neurol. 2024 Aug 29;15:1465232. doi: 10.3389/fneur.2024.1465232. eCollection 2024. Front Neurol. 2024. PMID: 39268067 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous